More about Vijaya Diagnostic Centre Limited
Fundamentals for Vijaya Diagnostic Centre Limited
Regulatory Filings for Vijaya Diagnostic Centre Limited
From Cost Center to Strategic Core: The Top 10 Trends Transforming Finance in 2026
CFOs Seize the Tech Purse Strings: How 2026 Budgets Are Fueling the AI Transformation
From Agentic AI to Tokenized Assets: The Fintech Trends Reshaping Financial Services
Forex Focus: How a Weakening Indian Rupee Could Reshape Markets in Q1 2026
Fundamentals for Vijaya Diagnostic Centre Limited
Business Operations:
Sector: HealthcareIndustry: Diagnostics & Research
Vijaya Diagnostic Centre Limited engages in the provision of diagnostic services for patients in India. It offers laboratory services, including clinical pathology, microbiology, haematology, serology, histopathology, cytogenetics, biochemistry, molecular diagnostics, CT scan, magnetic resonance imaging (MRI) scan, ultrasound, X-ray, cardiology, gastroenterology, nuclear medicine and PET/CT, and MRI-3T services. The company also provides health checkups and home sample collection services. Vijaya Diagnostic Centre Limited was founded in 1981 and is based in Hyderabad, India.
Revenue projections:
Vijaya Diagnostic Centre Limited's revenues are expected to fall below last year's, and this forecast tends to raise concerns among investors. A revenue drop can negatively impact the company's profitability, making investors more cautious about their positions due to the risks of declining financial performance.
Financial Ratios:
| currentRatio | 1.999000 |
|---|---|
| forwardPE | 48.001907 |
| debtToEquity | 42.224000 |
| earningsGrowth | 0.029000 |
| revenueGrowth | 0.102000 |
| grossMargins | 0.846840 |
| operatingMargins | 0.295490 |
| trailingEps | 14.730000 |
| forwardEps | 19.920000 |
VIJAYA's current ratio is 1.999, showing the company's capacity to service its short-term debt through its cash reserves and current assets. This is a positive indicator of liquidity, suggesting VIJAYA has no trouble covering its short-term financial obligations.
VIJAYA's positive gross and operating margins reflect its profitability and efficiency. These metrics demonstrate the company's ability to manage costs effectively while generating strong revenue, highlighting its solid financial health and operational effectiveness.
With a forward EPS greater than its trailing EPS, Vijaya Diagnostic Centre Limited is expected to see higher profitability this year. The forecasted increase in earnings reflects optimism about the company's financial growth and potential for improved performance over the prior year.
Price projections:
Vijaya Diagnostic Centre Limited's price has frequently been situated near the lower end of analysts' projections. This trend indicates that the stock is struggling to meet expectations, which could signal a need for improvements in performance or investor confidence.
Recommendation changes over time:
VIJAYA has received a favorable buy bias from analysts recently, positioning it as a solid investment opportunity. This sentiment may attract more investors, who view VIJAYA as a stable option to park their money and potentially benefit from the company's continued growth and profitability.
DISCLAIMER: We provide information and our musings based on events, but nothing on this site can be considered professional advice of any kind.
If you have enjoyed reading, spread the word:
Good prospects:
Companies with the best and the worst fundamentals.
Latest Regulatory Filings for NSE500
Companies with the best and the worst technicals.
Understanding Divergent House Price Movements Worldwide
The 2026 Tariff Tipping Point: When Trade Policy Reaches the Consumer
From Caracas to Commodities: The Market Impact of U.S.–China Friction